2-(2,2,2-Trifluoroethoxy)-1,3,2-dioxaphospholane 2-Oxide>95.0%(NMR)5g

Methyl 7-bromoheptanoate, 98.00%, 25g

2-(Pyrrolidin-2-yl)benzo[d]thiazole hydrochloride, 95.0%, 250mg

(R)-2-((6-((3-Amino-5-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)-3-methylbutan-1-ol, 97%, 1mg

1-(4H-1,2,4-Triazol-3-yl)piperazine, 97%, 250mg

6-Bromooxindole, 98.0%, 500g

5-Bromo-4-chloro-3-indolyl acetate, 95.0%, 5g

(5-FLUORO-6-METHYL-3-PYRIDYL)BORONIC ACID, 95%, 5g

2-(4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetic acid, 95.0%, 100mg

2,2',6,6'-Tetramethyl-4,4'-bipyridine, 98%, 100mg

5-(chloromethyl)-2-methanesulfonyl-1-(2-methylpropyl)-1H-imidazole, 95.0%, 2g

1-Oxy-nicotinic acid methyl ester, 95.0%, 250mg

[1,1'-Biphenyl]-3,3',5,5'-tetracarbaldehyde, 97%, 1g